Stay updated on Durvalumab vs Placebo in Early NSCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.
Latest updates to the Durvalumab vs Placebo in Early NSCLC Clinical Trial page
- Check3 days agoChange DetectedThe website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant change in this functionality.SummaryDifference1.0%
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
- Check39 days agoChange DetectedThe website has been updated from version v2.12.2 to v2.13.2, indicating a new release with potential improvements or features.SummaryDifference0.3%
- Check53 days agoChange DetectedThe website has removed a detailed section regarding data download options and fields related to clinical study information.SummaryDifference13%
- Check60 days agoChange DetectedSeveral key government health and information websites have been removed from the monitored list.SummaryDifference0.7%
- Check68 days agoChange DetectedThe study on Durvalumab with SBRT versus placebo in early stage unresected NSCLC has been updated from revision v2.12.1 to v2.12.2, with a new posting date of 2024-11-05.SummaryDifference18%
Stay in the know with updates to Durvalumab vs Placebo in Early NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab vs Placebo in Early NSCLC Clinical Trial page.